Cladribine.

Article Details

Citation
Copy to clipboard

Authors unspecified

Cladribine.

.

PubMed ID
31643872 [ View in PubMed
]
Abstract

Cladribine is a purine analogue and antineoplastic agent used primarily in the therapy of hairy cell leukemia. Cladribine is typically given intravenously daily for 7 days, usually as a single course, and has not been associated with serum enzyme elevations during therapy or with instances of clinically apparent acute liver injury with jaundice.

DrugBank Data that Cites this Article

Drugs